Cathay Biotech Inc.
688065.SS · SHH
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | CN¥37 | CN¥34 | CN¥30 | CN¥23 |
| - Cash | CN¥8 | CN¥9 | CN¥11 | CN¥5 |
| + Debt | CN¥0 | CN¥1 | CN¥2 | CN¥2 |
| Enterprise Value | CN¥30 | CN¥26 | CN¥21 | CN¥19 |
| Revenue | CN¥1 | CN¥1 | CN¥1 | CN¥1 |
| % Growth | -2.3% | 15.4% | 4.4% | – |
| Gross Profit | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 36.5% | 27.6% | 33.6% | 16.6% |
| EBITDA | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 18.8% | 20.9% | 28.6% | 9.8% |
| Net Income | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 16.2% | 19.2% | 17.7% | 19.4% |
| EPS Diluted | 0.2 | 0.24 | 0.23 | 0.25 |
| % Growth | -16.7% | 4.3% | -8% | – |
| Operating Cash Flow | -CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Capital Expenditures | -CN¥0 | -CN¥0 | -CN¥0 | -CN¥0 |
| Free Cash Flow | -CN¥0 | CN¥0 | -CN¥0 | -CN¥0 |